Most suppliers have participated or are participating in clinical trials. Medtronic and Boston Scientific are closer to completion and FDA submissions. Commercialization targets were originally anticipated at the end of 2023. Now it appears to be early to mid-2024.
NOTE: there are no FDA-approved PFA systems currently.